reduce insulin dose when starting glp-1 receptor agonist Clinical Focus on Agonists in Type 2 Diabetes Mellitus GLP-1 Receptor Agonists: An Alternative

Although the use of GLP-1 RAs prior to EGD or colonoscopy has resulted in poor outcomes in terms of poor visibility/preparation scores and the need for aborted/repeated procedures, their use prior to concurrent EGD and colonoscopy might not have the same detrimental effect

Among the latest advancements in pharmacotherapy for weight management are GLP-1 agonists which have shown promising results in aiding weight loss

In our study, GLP-1-RAs significantly reduced the (relative) number of MHD, with no patient from the GLP-1-RA group suffering from chronic headache at M6

The effects of bariatric surgery on islet function, insulin secretion, and glucose control

Breast Cancer Res Treat

Both are still on the market, but new prescriptions are increasingly going to semaglutide- or tirzepatide-based options because of greater effectiveness on blood sugar and weight